đšWhat is SLE ?
âĒī¸SLE āĻšāĻā§āĻā§ āĻāĻāĻāĻž autoimmune disease āϝā§āĻāĻž almost all system āĻā§ affect āĻāϰā§āĨ¤
đšDefinition āĻŦāϞāϤ⧠āĻā§āϞā§,
âĒī¸SLE is an autoimmune disease in which organs & cells undergo damage mediated by antibodies & immune complex.
âŦAge Group
âĒī¸āϏāĻŦ āĻŦā§ā§āϏā§āĻ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ āĻāĻŋāύā§āϤ⧠90% patients are women of child bearing yearsāĨ¤
âŦPathophysiology
âĒī¸SLE āĻāϰ PATHOPHYSIOLOGY āĻ āĻŋāĻāĻāĻžāĻŦā§ āĻŦāϞāϤ⧠āĻā§āϞ⧠āĻĒā§āϏā§āĻ āĻ āύā§āĻ āĻŦā§ āĻšā§ā§ āϝāĻžāĻŦā§āĨ¤ āϤāĻžāĻ āĻāϏā§āύ āĻāĻĒāĻžāϤāϤ āĻāĻžāĻ āĻāĻžāϞāĻžāύā§āϰ āĻŽāϤ⧠āĻāϰ⧠āĻāĻāĻā§ āĻŦā§āĻā§ āύā§āĻāĨ¤
âĒī¸SLE āĻšāĻā§āĻžāϰ āĻāύā§āϝ āĻĻā§āĻāĻāĻž āĻāĻŋāύāĻŋāϏ āĻĻāϰāĻāĻžāϰāĨ¤ āĻāĻāĻāĻž Bullet, āĻāϰā§āĻāĻāĻž TriggerāĨ¤
âĒī¸āϤāĻžāĻšāϞ⧠āĻāĻ Bullet & Trigger āĻāĻŋāĻāĻžāĻŦā§ āĻāĻžāĻ āĻāϰā§?
âĒī¸Bullet āĻšāĻā§āĻā§ āĻāĻŋāĻā§ Gene āϝā§āĻā§āϞ⧠āĻĨāĻžāĻāĻžāϰ āĻāĻžāϰāĻŖā§ āĻāĻĒāύāĻŋ SLE āĻāϰ āĻĒā§āϰāϤāĻŋ Susceptible āĻšā§ā§ āϝāĻžāĻŦā§āύāĨ¤ āϤāĻžāĻ āĻāĻā§āϞā§āĻā§ susceptibility gene āĻŦāϞāĻž āϝāĻžā§āĨ¤ āĻāϰāĻāĻŽ āĻ āύā§āĻāĻā§āϞ⧠gene āĻāĻā§āĨ¤ āϤāĻŦā§ āĻāĻāĻāĻž āĻāĻĨāĻž āĻŽāύ⧠āϰāĻžāĻāĻŦā§āύ āϝ⧠āĻāϰ āĻāĻžāϰāύ⧠C1q, C2 & C4 āĻāϰ deficiency āĻšā§āĨ¤ āĻĢāϞ⧠cellular function impaired āĻšā§āĨ¤
âĒī¸āĻ āύā§āϝāĻĻāĻŋāĻā§ āĻāĻŋāĻā§ āĻĢā§āϝāĻžāĻā§āĻāϰ SLE āĻāϰ trigger āĻšāĻŋāϏā§āĻŦā§ āĻāĻžāĻ āĻāϰā§āĨ¤ āϝā§āĻŽāύ-
âĢī¸Infection (Viral or Bacterial)â EBV
âĢī¸Environmental Toxin (Smoking)
âĢī¸UV- Light
âĢī¸Pregnancy
âĢī¸Certain Drugsâ Procainamide, Hydralazine, Isoniazide etc.

âĒī¸āĻāĻŦāĻžāϰ āĻāϏā§āύ Trigger āĻā§āĻĒā§ Bullet āĻĻāĻŋā§ā§ SLE āĻāϰ pathophysiology fire āĻāϰāĻŋāĨ¤
âĒī¸āϧāϰā§āύ, āĻā§āĻ āĻāĻāĻāύ UV-light āĻ āĻā§āĻŦ āĻŦā§āĻļāĻŋ exposed āĻšā§ā§ āĻā§āϞā§āĨ¤ āĻāĻ UV-light āϤāĻžāϰ cell āĻāϰ DNA āĻā§ āĻāĻŽāύāĻāĻžāĻŦā§ damage āĻāϰāϞ⧠āϝ⧠āĻ cell āĻā§āϞāĻžāϰ āĻāĻāύ apoptosis āĻšāϤ⧠āĻŦāĻžāϧā§āϝ āĨ¤

âĒī¸Apoptosis āĻšāĻā§āĻžāϰ āĻĢāϞ⧠āĻāĻŋāĻā§ Apoptotic body āϤā§āϰāĻŋ āĻšā§ āĻāĻŦāĻ cell āĻāϰ āĻā§āϤāϰ āĻĨā§āĻā§ Nuclear material āϏāĻŦ āĻŦā§āϰ āĻšā§ā§ āĻāϏā§āĨ¤ āϝā§āĻŽāύ â
âĢī¸DNA
âĢī¸Histones
âĢī¸Other proteins.
âĒī¸āĻāĻāύ bullet Susceptibility gene immune system āĻā§ āĻŦā§āĻāĻžā§ āϝ⧠āĻāĻ Nuclear Material āĻā§āϞ⧠foreign antigenāĨ¤ āĻāĻā§āϞāĻžāĻā§ āĻŽā§āϰ⧠āĻāϧāĻŽāϰāĻž āĻŦāĻžāύāĻžā§ āĻĻāĻŋāϤ⧠āĻšāĻŦā§āĨ¤ āϤāĻāύ āĻļā§āϰ⧠āĻšā§ attackāĨ¤
âĒī¸āϤāĻžāĻāĻžā§āĻžāĻ āĻāĻ susceptibility gene apoptotic body āĻāϰ clearance āĻāĻŽāĻŋā§ā§ āĻĻā§ā§āĨ¤ āĻĢāϞ⧠apoptotic body & nuclear antigen āĻāϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖ āĻŦāĻžā§āϤ⧠āĻĨāĻžāĻā§āĨ¤
âĒī¸āĻāϰāĻĒāϰ⧠āĻāĻāύāĻž easyāĨ¤ B cell āĻā§āϰāϤ⧠āĻāϏ⧠āĻĻā§āĻā§ āϝ⧠āĻāĻāĻžāύ⧠nuclear antigen āĻāϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖ āĻŦā§āĻļāĻŋāĨ¤ āϤāĻžāĻ āϏ⧠antibody produce āĻāϰāĻž āĻļā§āϰ⧠āĻāϰā§āĨ¤
âĢī¸Antinuclear antibody (ANA)
âĢī¸Anti dsAntibody
âĢī¸Antiphospholipid antibody
âĢī¸Anti smAntibody
âĒī¸āĻāĻ antibody nuclear antigens āĻāϰ āϏāĻžāĻĨā§ āĻŽāĻŋāϞā§āĻŽāĻŋāĻļā§ āϤā§āϰāĻŋ āĻāϰ⧠Antigen-Antibody ComplexāĨ¤ āĻāϰāĻĒāϰ āϤāĻž blood āĻāϰ āϏāĻžāĻĨā§ āĻŦāĻŋāĻāĻŋāύā§āύ Organ āĻ āĻāĻŋā§ā§ deposit āĻšā§ā§ āϏā§āĻāĻžāύ⧠inflammation āĻāϰā§āĨ¤ āĻāϞā§āĻāĻŋāĻŽā§āĻāϞāĻŋ tissue & organ damage āĻšā§āĨ¤
âŦClinical feature
âĢī¸Symptom āĻļā§āϰ⧠āĻšā§ fever, weight loss āĻĻāĻŋā§ā§āĨ¤ āϤāĻžāϰāĻĒāϰ āϝ⧠āϝ⧠system involve āĻāϰ⧠āϤāĻžāϰ symptom āĻĻā§āĻāĻž āĻĻā§ā§āĨ¤
đšWhen skin is involved
âĢī¸Malar Rash
âĢī¸Discoid rash
âĢī¸Urticarial Eruption
âĢī¸Livedo reticularis
âĢī¸Raynaudâs Phenomenon
SLE can present with Raynaudâs PhenomenonāĨ¤ āĻāĻāĻžāĻā§ Primary Raynaudâs Phenomenon āĻĨā§āĻā§ āĻāϞāĻžāĻĻāĻž āĻāϰāĻžāϰ āĻāύā§āϝ āĻāĻŋāĻā§ criteria āĻāĻā§āĨ¤
âĢī¸Age> 25
âĢī¸Absence of family History
âĢī¸Male
âĢī¸Examination of capillary nail fold show loss of normal loop pattern
đšWhen joints are involved
âĢī¸Arthritis
âĢī¸Jaccoudâs arthropathy (if tendon damage)

đšWhen kidney is involved
âĢī¸Proliferative Glomerulonephritis
âĢī¸Presents with
âĢī¸Heavy haematuria
âĢī¸Proteinuria
âĢī¸Cast in urine
đšWhen cardiovascular system is involved
âĢī¸Pericarditis
âĢī¸Myocarditis
âĢī¸Libman-Sacks Endocarditis
âĢī¸Hypercoagulability
âĢī¸Risk of MI & Stroke
đšWhen Lung is involved
âĢī¸Pleuritic pain
âĢī¸Pleural effusion
âĢī¸Pneumonitis
âĢī¸Pulmonary fibrosis leads to breathlessness
đšNeurological
âĢī¸Fatigue
âĢī¸Headache
âĢī¸Seizure
âĢī¸Psychosis
âĢī¸Hallucination
âĢī¸Chorea
đšHaematological
âĢī¸Neutropenia
âĢī¸Lymphopenia
âĢī¸Thrombocytopenia
âĢī¸Haemolytic anemia
đšGastrointestinal
âĢī¸Oral Ulcer
âĢī¸Abdominal Pain
âĢī¸Bowel infarction or perforation
âŦDiagnostic criteria
âĒī¸āύāĻŋāĻā§ 11 āĻāĻž criteria āĻāĻā§āĨ¤ āϤāĻžāϰ āĻŽāϧā§āϝ⧠4 āĻāĻž āĻĒāĻžāĻā§āĻž āĻā§āϞā§āĻ suspect āĻāϰāĻŦā§āύ SLEāĨ¤
âĢī¸Malar rash
âĢī¸Discoid rash
âĢī¸Photosensitivity
âĢī¸Oral ulcers
âĢī¸Arthritis
âĢī¸Serositis
âĢī¸Renal disorder
âĢī¸Neurological disorder
âĢī¸Haematological disorder
âĢī¸Immunological test to see presence of antibody
âĢī¸Antinuclear antibody
âŦInvestigation
âĢī¸Complete blood count with Erythrocyte Segmentation Rate
âĢī¸Urine analysis
âĢī¸Serum Complement level
âĢī¸Autoantibody test
âĢī¸Skin biopsy
âĢī¸Computed Tomography(CT)/Magnetic Resonance Imaging (MRI)in cerebral lupus
âĢī¸Electrocardiogram
âŦTreatment
đšEducate the patient about the disease
đšAdvice to avoid Sun & UV light exposure
đšMild to moderate disease
âĢī¸Analgesics & NSAID for pain
âĢī¸Hydroxychloroquine
âĢī¸Gucocorticoids
âĢī¸Azathioprine
đšSevere & Life threatening disease
âĢī¸High dose glucocorticoid & immunosuppressants
Commonly used regimen is pulsed methylprednisolone+cyclophosphamide
đšAfter that maintenance therapy is given.
Reefat Adil
Session:2015-16
JRRMC.
Platform Academic/Avijit Bagchi